Open AccessBebtelovimab: The FDA-approved Monoclonal Antibody for Treating Patients with Mild-to-Moderate COVID-19
Author(s) -
Pouya Safarzadeh Kozani,
Mehdi Sheikhi,
Narges Baharifar,
Setareh Dashti Shokoohi,
Sara Sheikhi,
Seyed Mohamad Javad Mirarefin,
Pooria Safarzadeh Kozani,
Abdolkarim Sheikhi
Publication year - 2022
Publication title -
trends in medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2783-2090
DOI - 10.5812/tms-130706
Subject(s) - covid-19 , medicine , monoclonal antibody , virology , drug approval , pharmacology , antibody , immunology , drug , infectious disease (medical specialty) , disease , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom